Gene · 24137
Papers1,342
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,342
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| KIF4A stabilizes TDP43 to promote DNA damage repair and temozolomide resistance in glioblastoma. | Biochem Pharmacol | 2026 | 42785594 | PubTator, text mining | PubMed |
| KIF4A drives esophageal squamous cell carcinoma via Wnt/β‑catenin signaling and predicts poor prognosis. | Mol Med Rep | 2026 | 42725385 | PubTator, text mining | PubMed |
| Kinesins in Bladder Cancer: Integrating Molecular Mechanisms and Treatment Approaches. | Cell Biol Int | 2026 | 42529891 | PubTator, text mining | PubMed |
| KIF4A-KIF4B Paralog as a Prognostic Biomarker in Lung Adenocarcinoma. | Medicina (Kaunas) | 2026 | 42512966 | PubTator, text mining | PubMed |
| A bioinformatics analysis of KIF transcriptomic subtyping reveals prognostic heterogeneity and differential therapeutic responses in cervical cancer. | Oncol Lett | 2026 | 42491333 | PubTator, text mining | PubMed |
Retraction notice to "Integrative PPI network and random forest analysis identifies KIF4A, TOP2A, and ASPM protein macromolecules as novel protein biomarkers in renal carcinoma pathogenesis" [International Journal of Biological Macromolecules 311 (2025) 144058]. | Int J Biol Macromol | 2026 | 42486758 | PubTator, text mining | PubMed |
| ERCC6L in human cancers: oncogenic functions, molecular mechanisms, and clinical implications as a prognostic biomarker and therapeutic target. | Front Oncol | 2026 | 42459306 | PubTator, text mining | PubMed |
| Reanalysis of Public Transcriptomes Reveals Shared Immune Signatures Between Major Depressive Disorder And Dermatomyositis With Single-Cell Context. | J Vis Exp | 2026 | 42441576 | PubTator, text mining | PubMed |
| Acidosis-associated gene signature defines novel subtypes and dual-target therapeutic candidates in breast cancer. | J Transl Med | 2026 | 42374456 | PubTator, text mining | PubMed |
| Low KIF4A expression is associated with gastric cancer progression and aggressive phenotypes. | Sci Rep | 2026 | 42251143 | PubTator, text mining | PubMed |
| Atomic force microscopy identifies filamentous structures comprising mitotic chromosomes. | Biomed Res | 2026 | 42178239 | PubTator, text mining | PubMed |
| Identification of replication factor C subunit 4 as a potential therapeutic target in esophageal squamous cell carcinoma based on bioinformatic analysis and machine learning. | Discov Oncol | 2026 | 42171922 | PubTator, text mining | PubMed |
| Prognostic biomarkers and regulatory mechanisms associated with lysine β-hydroxybutyrylation modification in prostate cancer. | Front Mol Biosci | 2026 | 42037647 | PubTator, text mining | PubMed |
| A competing TMPO-AS1-let-7b-5p-kinesin superfamily RNA network predicts poor lung cancer patient survival. | Rep Pract Oncol Radiother | 2026 | 41937877 | PubTator, text mining | PubMed |
| Spatial multi-omics characterization of neuroblastoma reveals ferroptosis-associated metabolic features in high-risk tumors. | Genome Med | 2026 | 41918107 | PubTator, text mining | PubMed |
| Cell-Cell Interactome-Based Pathogenesis and Therapies for Osteosarcoma. | Cells | 2026 | 41892359 | PubTator, text mining | PubMed |
| Non-invasive host transcriptome and HPV oncogene expression map the molecular landscape of HPV-driven cervical lesions. | PLoS One | 2026 | 41855211 | PubTator, text mining | PubMed |
| Polar chromosomes are rescued from missegregation by spindle elongation-driven microtubule pivoting. | Nat Commun | 2026 | 41844586 | PubTator, text mining | PubMed |
| CPNE3 promotes colorectal cancer progression by regulating KIF4-mediated autophagy. | J Gastrointest Oncol | 2026 | 41816564 | PubTator, text mining | PubMed |
| Cell type-specific network analysis in Diversity Outbred mice identifies genes potentially responsible for human bone mineral density GWAS associations. | Elife | 2026 | 41811178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/24137/papers